Endocrinology

Glycemic Impact of NNS Via the Gut Microbiome

Conditions: Prediabetes
Interventions: Dietary Supplement: Sucralose
Sponsors: Tufts University; Tufts Medical Center
Enrolling by invitation

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication

Conditions: Overweight; Obesity; Type 2 Diabetes
Interventions: Drug: Tirzepatide; Drug: Zenagamtide
Sponsors: Novo Nordisk A/S
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
CKD Awareness, Referrals, Education, and Support Intervention for Early-Stage CKD

Conditions: Chronic Kidney Disease; Diabetes
Interventions: Behavioral: CKD Awareness, Referrals, Education, and Support (CARES); Behavioral: Attention control
Sponsors: University of Illinois at Chicago; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Chicago
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
KPSC MNT Pilot RCT

Conditions: Type 2 Diabetes
Interventions: Behavioral: Diabetes Medical Nutrition Therapy (DM MNT) Pilot
Sponsors: Kaiser Permanente
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 10, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Tracking Income Dynamics and Everyday Health Study

Conditions: HIV; Hypertension; Hypercholerolemia; Type 2 Diabetes
Interventions: Other: Preventative health review invitation early in SNAP cycle; Other: Financial counseling invitation early in the SNAP cycle; Other: Aim 3 follow-up call early in the SNAP period; Other: Preventative health review invitation late in SNAP cycle; Other: Financial counseling invitation late in the SNAP cycle; Other: Aim 3 follow-up call late in the SNAP cycle
Sponsors: University of Pennsylvania; National Institute on Aging (NIA)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

Conditions: Type 1 Diabetes; Type 2 Diabetes
Interventions: Device: Next Generation Extended Wear Sensors
Sponsors: Medtronic MiniMed, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes

Conditions: Obesity or Overweight; Type 2 Diabetes
Interventions: Combination Product: Petrelintide; Combination Product: Placebo
Sponsors: Hoffmann-La Roche; Zealand Pharma
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Continuous Delivery of Ranibizumab Via the Port Delivery System for Proliferative Diabetic Retinopathy-related Vitreous Hemorrhage With Pars Plana Vitrectomy and Limited PRP.

Conditions: Proliferative Diabetic Retinopathy (DR); Vitrectomy; Diabetic Retinopathy (DR); Diabetes (DM)
Interventions: Device: PDS Implant filled with 100 mg/mL Ranibizumab; Drug: Ranibizumab
Sponsors: Southeast Retina Center, Georgia; Genentech, Inc.
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a Tumor

Conditions: Tumor-associated Hyperinsulinism (Tumor HI)
Interventions: Drug: Ersodetug (9 mg/kg) + SOC
Sponsors: Rezolute
Available

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 8, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine
Inspiratory Muscle Strength Training in Adults With Type 1 Diabetes

Conditions: Type 1 Diabetes
Interventions: Device: High-Resistance Inspiratory Muscle Strength Training; Device: Sham Inspiratory Muscle Strength Training
Sponsors: Florida State University; National Heart, Lung, and Blood Institute (NHLBI)
Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

October 7, 2026Comments OffClinicalTrials.gov | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine